Download PDF
CC BY 4.0 · World J Nucl Med 2024; 23(01): 043-045
DOI: 10.1055/s-0044-1778710
Case Report

Unusual Metastatic Sites of Testis and Rectum in Prostate Cancer Detected by 68Ga-PSMA-11 PET/CT Imaging at Initial Staging

Rahul V. Parghane
1   Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Parel, Mumbai, Maharashtra, India
2   Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Sandip Basu 
1   Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Parel, Mumbai, Maharashtra, India
2   Homi Bhabha National Institute, Mumbai, Maharashtra, India
› Author Affiliations Funding None.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Imaging plays a pivotal role in defining the extent of disease and deciding therapeutic strategies in recently diagnosed high-risk prostate cancer. Standard-of-care conventional imaging may often miss rare metastatic disease sites. We herein present a unique case of prostate cancer where 68Ga-PSMA-11 positron emission tomography (PET)/computed tomography (CT) detected two unusual metastatic sites (testis and rectum) in a single patient at initial staging, resulting in an accurate determination of the extent of disease, more tailored multimodal treatment planning, and exploration of the theragnostic potential.

Keywords

prostate cancer - prostate-specific membrane antigen - 68Ga-PSMA-11 PET/CT - theranostics - metastatic disease to the testes and rectum


Publication History

Article published online:
22 January 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Zumsteg ZS, Spratt DE, Romesser PB. et al. The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy. Eur Urol 2015; 67 (06) 1009-1016
    CrossrefPubMedGoogle Scholar
  • 2 Eggener SE, Scardino PT, Walsh PC. et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol 2011; 185 (03) 869-875
    CrossrefPubMedGoogle Scholar
  • 3 Mohler JL, Antonarakis ES, Armstrong AJ. et al. Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2019; 17 (05) 479-505
    CrossrefPubMedGoogle Scholar
  • 4 Wang CH, Yang S. Testicular metastasis from hepatocellular carcinoma. Int J Urol 2006; 13 (07) 1033-1034
    CrossrefPubMedGoogle Scholar
  • 5 Abou Heidar NF, Bustros G, El-Asmar JM, Sabatto BZ, Degheili JA. Isolated testicular metastasis diagnosed more than a decade and a half post primary treatment for prostate cancer. Case Rep Oncol Med 2019; 4956954
    PubMedGoogle Scholar
  • 6 Villers A, McNeal JE, Freiha FS, Boccon-Gibod L, Stamey TA. Invasion of Denonvilliers' fascia in radical prostatectomy specimens. J Urol 1993; 149 (04) 793-798
    CrossrefPubMedGoogle Scholar
  • 7 Nwankwo N, Mirrakhimov AE, Zdunek T, Bucher N. Prostate adenocarcinoma with a rectal metastasis. BMJ Case Rep 2013; bcr2013009503
    Google Scholar
  • 8 Fendler WP, Calais J, Eiber M. et al. Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial. JAMA Oncol 2019; 5 (06) 856-863
    CrossrefPubMedGoogle Scholar
  • 9 Hofman MS, Lawrentschuk N, Francis RJ. et al; proPSMA Study Group Collaborators. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet 2020; 395 (10231): 1208-1216
    CrossrefPubMedGoogle Scholar
  • 10 Barbosa FG, Queiroz MA, Nunes RF. et al. Revisiting prostate cancer recurrence with PSMA PET: atlas of typical and atypical patterns of spread. Radiographics 2019; 39 (01) 186-212
    CrossrefPubMedGoogle Scholar
  • 11 Osman MM, Iravani A, Hicks RJ, Hofman MS. Detection of synchronous primary malignancies with 68Ga-labeled prostate-specific membrane antigen PET/CT in patients with prostate cancer: frequency in 764 patients. J Nucl Med 2017; 58 (12) 1938-1942
    CrossrefPubMedGoogle Scholar